MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop
Authors
Keywords
Mutant p53-miR-223-3p-feedback loop-lung squamous cell carcinoma
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-12
DOI
10.1186/s13046-019-1079-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies
- (2018) Fred R. Hirsch et al. Clinical Lung Cancer
- Long noncoding RNA SNHG1 promotes non-small cell lung cancer progression by up-regulating MTDH via sponging miR-145-5p
- (2018) Qingchun Lu et al. FASEB JOURNAL
- Methylation of the HOXA10 Promoter Directs miR-196b-5p–Dependent Cell Proliferation and Invasion of Gastric Cancer Cells
- (2018) Linlin Shao et al. MOLECULAR CANCER RESEARCH
- Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
- (2017) Xuetian Yue et al. JOURNAL OF MOLECULAR BIOLOGY
- Lung cancer: current therapies and new targeted treatments
- (2017) Fred R Hirsch et al. LANCET
- Diagnosis value of aberrantly expressed microRNA profiles in lung squamous cell carcinoma: a study based on the Cancer Genome Atlas
- (2017) Sheng Yang et al. PeerJ
- Patient-Derived Xenograft Models of Non-Small Cell Lung Cancer and Their Potential Utility in Personalized Medicine
- (2017) Katherine M. Morgan et al. Frontiers in Oncology
- Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma
- (2016) Licun Wu et al. CLINICAL CANCER RESEARCH
- MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD
- (2016) Caroline Leuenberger et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- MicroRNA-223 Promotes Tumor Progression in Lung Cancer A549 Cells via Activation of the NF-κB Signaling Pathway
- (2016) Li Huang et al. ONCOLOGY RESEARCH
- The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers
- (2015) S T Kundu et al. ONCOGENE
- Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
- (2015) Ryo Yamashita et al. Cancer Medicine
- miRNA expression profiles associated with diagnosis and prognosis in lung cancer
- (2014) Chunyang Jiang et al. Expert Review of Anticancer Therapy
- MicroRNA-223 controls susceptibility to tuberculosis by regulating lung neutrophil recruitment
- (2013) Anca Dorhoi et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-223: infection, inflammation and cancer
- (2013) M. Haneklaus et al. JOURNAL OF INTERNAL MEDICINE
- Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells
- (2013) S Masciarelli et al. ONCOGENE
- miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2
- (2013) WEIQI NIAN et al. Oncology Letters
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
- (2012) S. Kopetz et al. CLINICAL CANCER RESEARCH
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis
- (2011) X. Tan et al. CLINICAL CANCER RESEARCH
- Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549)
- (2011) Hai-Bo Bian et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14)
- (2011) R Wang et al. ONCOGENE
- The Ability to Form Primary Tumor Xenografts Is Predictive of Increased Risk of Disease Recurrence in Early-Stage Non-Small Cell Lung Cancer
- (2010) T. John et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now